申请人:Galecto Biotech AB
公开号:US10774102B2
公开(公告)日:2020-09-15
An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
本发明的一个实施方案涉及通式化合物。通式化合物适用于治疗哺乳动物(如人类)中与半凝集素(如半凝集素-3)与配体结合有关的紊乱的方法。此外,本发明的一个实施方案涉及一种治疗哺乳动物(如人类)中与半凝集素(如半凝集素-3)与配体结合有关的紊乱的方法。